Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.
Commission
File Number 001-33269
CHINA
HEALTHCARE ACQUISITION
CORP
(Exact name
of registrant as specified
in its charter)
1233
Encino Drive,
Pasadena, CA 91108 (626) 568-9924
(Address,
including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, par value $0.0001
per share;
Common Stock Purchase Warrants;
Units
consisting of one share of Common Stock and
two
warrants;
(Title
of each class of securities covered by
this Form)
None
(Title of
all other classes of securities for which a duty to file reports under section
13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate
or suspend the duty to file reports:
|
Rulel2g-4(a)(1)
|
o |
|
Rulel2g-4(a)(2)
|
o |
|
Rulel2h-3(b)(l)(i)
|
x |
| Rule
12h-3(b)(l)(ii) |
o |
|
Rule
15d-6
|
o |
Approximate
number of holders of record as of the certification or notice date:
Common Stock - 8 holders of
record
Common
Stock Purchase Warrants - 2 holders of record
Units
consisting of one share of Common Stock and two Warrants - 0 - holders
of record
Pursuant
to the requirements of the Securities Exchange Act of 1934 China Healthcare
Acquisition Corp has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
|
Date:
August 13,
2009
|
By:
|
/s/
Alwin Tan
|
| |
|
Alwin
Tan |
|
|
|
President
and Chief Executive Officer
|